» Articles » PMID: 34690803

Effectiveness of Some Vitamins in the Prevention of Cardiovascular Disease: A Narrative Review

Overview
Journal Front Physiol
Date 2021 Oct 25
PMID 34690803
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

By virtue of their regulatory role in various metabolic and biosynthetic pathways for energy status and cellular integrity, both hydro-soluble and lipo-soluble vitamins are considered to be involved in maintaining cardiovascular function in health and disease. Deficiency of some vitamins such as vitamin A, B, folic acid, C, D, and E has been shown to be associated with cardiovascular abnormalities whereas supplementation with these vitamins has been claimed to reduce cardiovascular risk for hypertension, atherosclerosis, myocardial ischemia, arrhythmias, and heart failure. However, the data from several experimental and clinical studies for the pathogenesis of cardiovascular disease due to vitamin deficiency as well as therapy due to different vitamins are conflicting. In this article, we have attempted to review the existing literature on the role of different vitamins in cardiovascular disease with respect to their deficiency and supplementation in addition to examining some issues regarding their involvement in heart disease. Although both epidemiological and observational studies have shown some merit in the use of different antioxidant vitamins for the treatment of cardiovascular disorders, the results are not conclusive. Furthermore, in view of the complexities in the mechanisms of different cardiovascular disorders, no apparent involvement of any particular vitamin was seen in any specific cardiovascular disease. On the other hand, we have reviewed the evidence that deficiency of vitamin B promoted KCl-induced Ca entry and reduced ATP-induced Ca-entry in cardiomyocytes in addition to decreasing sarcolemmal (SL) ATP binding. The active metabolite of vitamin B, pyridoxal 5'-phosphate, attenuated arrhythmias due to myocardial infarction (MI) as well as cardiac dysfunction and defects in the sarcoplasmic reticulum (SR) Ca-transport in the ischemic-reperfused hearts. These observations indicate that both deficiency of some vitamins as well as pretreatments with different vitamins showing antioxidant activity affect cardiac function, metabolism and cation transport, and support the view that antioxidant vitamins or their metabolites may be involved in the prevention rather than the therapy of cardiovascular disease.

Citing Articles

Pyridoxal 5'-phosphate and risk of stroke: triangulation of evidence from a nationally representative cohort and bidirectional Mendelian randomization analysis.

Zhang M, Zhong J, Peng Y, Hao L, Xiao B EPMA J. 2025; 16(1):95-111.

PMID: 39991095 PMC: 11842680. DOI: 10.1007/s13167-024-00392-2.


Vitamin C: A Comprehensive Review of Its Role in Health, Disease Prevention, and Therapeutic Potential.

Alberts A, Moldoveanu E, Niculescu A, Grumezescu A Molecules. 2025; 30(3).

PMID: 39942850 PMC: 11820684. DOI: 10.3390/molecules30030748.


Investigating the causal relationship between human blood metabolites and pulmonary hypertension: a two-sample Mendelian randomization study.

Zeng X, Zhong B Front Cardiovasc Med. 2024; 11:1304986.

PMID: 39473890 PMC: 11518716. DOI: 10.3389/fcvm.2024.1304986.


The Efficacy of Vitamins in the Prevention and Treatment of Cardiovascular Disease.

Tappia P, Shah A, Dhalla N Int J Mol Sci. 2024; 25(18).

PMID: 39337248 PMC: 11432297. DOI: 10.3390/ijms25189761.


Therapeutic effect of targeted antioxidant natural products.

Mukherjee S, Chopra H, Goyal R, Jin S, Dong Z, Das T Discov Nano. 2024; 19(1):144.

PMID: 39251461 PMC: 11383917. DOI: 10.1186/s11671-024-04100-x.


References
1.
Pancharuniti N, Lewis C, SAUBERLICH H, Perkins L, Go R, Alvarez J . Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr. 1994; 59(4):940-8. DOI: 10.1093/ajcn/59.4.940. View

2.
Dakshinamurti K, Wang X, Musat S, Dandekar M, Dhalla N . Alterations of KCl- and ATP-induced increase in [Ca2+]i in cardiomyocytes from vitamin B6 deficient rats. Can J Physiol Pharmacol. 1999; 76(9):837-42. DOI: 10.1139/cjpp-76-9-837. View

3.
van der Pol A, van Gilst W, Voors A, van der Meer P . Treating oxidative stress in heart failure: past, present and future. Eur J Heart Fail. 2018; 21(4):425-435. PMC: 6607515. DOI: 10.1002/ejhf.1320. View

4.
Muscogiuri G, Annweiler C, Duval G, Karras S, Tirabassi G, Salvio G . Vitamin D and cardiovascular disease: From atherosclerosis to myocardial infarction and stroke. Int J Cardiol. 2017; 230:577-584. DOI: 10.1016/j.ijcard.2016.12.053. View

5.
Surdu A, Pinzariu O, Ciobanu D, Negru A, Cainap S, Lazea C . Vitamin D and Its Role in the Lipid Metabolism and the Development of Atherosclerosis. Biomedicines. 2021; 9(2). PMC: 7916166. DOI: 10.3390/biomedicines9020172. View